PRKDC and medullary thyroid gland carcinoma: Previous research has demonstrated that other receptor tyrosine kinase pathways are capable of activating DNA-PKcs, therefore; it is perhaps not surprising that our research has demonstrated this phenomena to occur in the RET signaling pathway in MTC as well [29].